Ambipar Emergency Response
AMBIQ
$0.51
$0.1128.30%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.80% | 24.72% | 28.92% | 43.47% | 59.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.80% | 24.72% | 28.92% | 43.47% | 59.55% |
| Cost of Revenue | 22.04% | 27.06% | 29.67% | 44.62% | 62.18% |
| Gross Profit | -10.28% | 14.94% | 25.76% | 38.86% | 49.44% |
| SG&A Expenses | 5.49% | 8.66% | 31.63% | 33.38% | 10.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -132.35% | -101.60% | -109.38% | -107.90% | 973.54% |
| Total Operating Expenses | 14.50% | 21.29% | 22.20% | 34.32% | 70.77% |
| Operating Income | 23.70% | 45.03% | 71.72% | 104.97% | 14.03% |
| Income Before Tax | 12.42% | -3.72% | 63.47% | 63.87% | -49.52% |
| Income Tax Expenses | -32.56% | -25.88% | 25.17% | 76.62% | 112.48% |
| Earnings from Continuing Operations | 206.78% | 14.96% | 90.47% | 55.07% | -88.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.73% | 1.02% | -34.62% | -70.47% | -214.75% |
| Net Income | 83.78% | 57.52% | 282.35% | 30.07% | -137.17% |
| EBIT | 23.70% | 45.03% | 71.72% | 104.97% | 14.03% |
| EBITDA | 23.91% | 45.91% | 55.58% | 85.17% | 22.31% |
| EPS Basic | -265.05% | -6.88% | 255.37% | 7,384.21% | -82.76% |
| Normalized Basic EPS | -83.29% | -17.74% | 232.22% | 1,556.14% | 19.93% |
| EPS Diluted | -927.27% | -26.92% | 366.67% | 5,536.84% | -107.36% |
| Normalized Diluted EPS | -112.01% | -24.48% | 331.90% | 1,316.67% | -3.85% |
| Average Basic Shares Outstanding | -38.30% | -60.82% | -71.29% | -77.35% | -65.70% |
| Average Diluted Shares Outstanding | -33.30% | -56.75% | -68.00% | -73.49% | -63.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -4.15% | -0.52% | -0.93% | -0.34% | -503.21% |